A Belgian ancestral haplotype harbours a highly prevalent mutation for I7q21-linked tau-negative FTLD

Julie Van Der Zee, Rosa V Rademakers, Sebastiaan Engelborghs, Ilse Gijselinck, Veerle Bogaerts, Rik Vandenberghe, Patrick Santens, Jo Caekebeke, Tim De Pooter, Karin Peeters, Ursula Lübke, Marleen Van Den Broeck, Jean Jacques Martin, Marc Cruts, Peter P. De Deyn, Christine Van Broeckhoven, Bart Dermaut

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Among patients with frontotemporal lobar degeneration (FTLD), the respective frequencies of dominant I7q21-linked tau-negative FTLD (with unidentified molecular defect) and I7q21-linked tau-positive FTLD (due to MAPT mutations) remain unknown. Here, in a series of 98 genealogically unrelated Belgian FTLD patients, we identified an ancestral 8 cM MAPT containing haplotype in two patients belonging to multiplex families DR2 and DR8, without demonstrable MAPT mutations, in which FTLD was conclusively linked to 17q21 [maximum summed log of the odds (LOD) score of 5.28 at D17S931]. Interestingly, the same DR2-DR8 ancestral haplotype was observed in five additional familial FTLD patients, indicative of a founder effect. In the FTLD series, the DR2-DR8 ancestral haplotype explained 7% (7 out of 98) of FTLD and 17% (7 out of 42) of familial FTLD and was seven times more frequent than MAPT mutations (1 out of 98 or 1%). Clinically, DR2-DR8 haplotype carriers presented with FTLD often characterized by language impairment, and in one carrier the neuropathological diagnosis was FTLD with rare tau-negative ubiquitin-positive inclusions. Together, these results strongly suggest that the DR2-DR8 founder haplotype at 17q21 harbours a tau-negative FTLD causing mutation that is a much more frequent cause of FTLD in Belgium than MAPT mutations.

Original languageEnglish (US)
Pages (from-to)841-852
Number of pages12
JournalBrain
Volume129
Issue number4
DOIs
StatePublished - Apr 2006
Externally publishedYes

Fingerprint

Frontotemporal Lobar Degeneration
Haplotypes
Mutation
Founder Effect
Belgium
Ubiquitin

Keywords

  • 17q21
  • Founder mutation
  • Frontotemporal lobar degeneration
  • Tau-negative
  • Ubiquitin-positive

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Van Der Zee, J., Rademakers, R. V., Engelborghs, S., Gijselinck, I., Bogaerts, V., Vandenberghe, R., ... Dermaut, B. (2006). A Belgian ancestral haplotype harbours a highly prevalent mutation for I7q21-linked tau-negative FTLD. Brain, 129(4), 841-852. https://doi.org/10.1093/brain/awl029

A Belgian ancestral haplotype harbours a highly prevalent mutation for I7q21-linked tau-negative FTLD. / Van Der Zee, Julie; Rademakers, Rosa V; Engelborghs, Sebastiaan; Gijselinck, Ilse; Bogaerts, Veerle; Vandenberghe, Rik; Santens, Patrick; Caekebeke, Jo; De Pooter, Tim; Peeters, Karin; Lübke, Ursula; Van Den Broeck, Marleen; Martin, Jean Jacques; Cruts, Marc; De Deyn, Peter P.; Van Broeckhoven, Christine; Dermaut, Bart.

In: Brain, Vol. 129, No. 4, 04.2006, p. 841-852.

Research output: Contribution to journalArticle

Van Der Zee, J, Rademakers, RV, Engelborghs, S, Gijselinck, I, Bogaerts, V, Vandenberghe, R, Santens, P, Caekebeke, J, De Pooter, T, Peeters, K, Lübke, U, Van Den Broeck, M, Martin, JJ, Cruts, M, De Deyn, PP, Van Broeckhoven, C & Dermaut, B 2006, 'A Belgian ancestral haplotype harbours a highly prevalent mutation for I7q21-linked tau-negative FTLD', Brain, vol. 129, no. 4, pp. 841-852. https://doi.org/10.1093/brain/awl029
Van Der Zee J, Rademakers RV, Engelborghs S, Gijselinck I, Bogaerts V, Vandenberghe R et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for I7q21-linked tau-negative FTLD. Brain. 2006 Apr;129(4):841-852. https://doi.org/10.1093/brain/awl029
Van Der Zee, Julie ; Rademakers, Rosa V ; Engelborghs, Sebastiaan ; Gijselinck, Ilse ; Bogaerts, Veerle ; Vandenberghe, Rik ; Santens, Patrick ; Caekebeke, Jo ; De Pooter, Tim ; Peeters, Karin ; Lübke, Ursula ; Van Den Broeck, Marleen ; Martin, Jean Jacques ; Cruts, Marc ; De Deyn, Peter P. ; Van Broeckhoven, Christine ; Dermaut, Bart. / A Belgian ancestral haplotype harbours a highly prevalent mutation for I7q21-linked tau-negative FTLD. In: Brain. 2006 ; Vol. 129, No. 4. pp. 841-852.
@article{1472be5072e24fc6b7b4e841bee6e0e5,
title = "A Belgian ancestral haplotype harbours a highly prevalent mutation for I7q21-linked tau-negative FTLD",
abstract = "Among patients with frontotemporal lobar degeneration (FTLD), the respective frequencies of dominant I7q21-linked tau-negative FTLD (with unidentified molecular defect) and I7q21-linked tau-positive FTLD (due to MAPT mutations) remain unknown. Here, in a series of 98 genealogically unrelated Belgian FTLD patients, we identified an ancestral 8 cM MAPT containing haplotype in two patients belonging to multiplex families DR2 and DR8, without demonstrable MAPT mutations, in which FTLD was conclusively linked to 17q21 [maximum summed log of the odds (LOD) score of 5.28 at D17S931]. Interestingly, the same DR2-DR8 ancestral haplotype was observed in five additional familial FTLD patients, indicative of a founder effect. In the FTLD series, the DR2-DR8 ancestral haplotype explained 7{\%} (7 out of 98) of FTLD and 17{\%} (7 out of 42) of familial FTLD and was seven times more frequent than MAPT mutations (1 out of 98 or 1{\%}). Clinically, DR2-DR8 haplotype carriers presented with FTLD often characterized by language impairment, and in one carrier the neuropathological diagnosis was FTLD with rare tau-negative ubiquitin-positive inclusions. Together, these results strongly suggest that the DR2-DR8 founder haplotype at 17q21 harbours a tau-negative FTLD causing mutation that is a much more frequent cause of FTLD in Belgium than MAPT mutations.",
keywords = "17q21, Founder mutation, Frontotemporal lobar degeneration, Tau-negative, Ubiquitin-positive",
author = "{Van Der Zee}, Julie and Rademakers, {Rosa V} and Sebastiaan Engelborghs and Ilse Gijselinck and Veerle Bogaerts and Rik Vandenberghe and Patrick Santens and Jo Caekebeke and {De Pooter}, Tim and Karin Peeters and Ursula L{\"u}bke and {Van Den Broeck}, Marleen and Martin, {Jean Jacques} and Marc Cruts and {De Deyn}, {Peter P.} and {Van Broeckhoven}, Christine and Bart Dermaut",
year = "2006",
month = "4",
doi = "10.1093/brain/awl029",
language = "English (US)",
volume = "129",
pages = "841--852",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - A Belgian ancestral haplotype harbours a highly prevalent mutation for I7q21-linked tau-negative FTLD

AU - Van Der Zee, Julie

AU - Rademakers, Rosa V

AU - Engelborghs, Sebastiaan

AU - Gijselinck, Ilse

AU - Bogaerts, Veerle

AU - Vandenberghe, Rik

AU - Santens, Patrick

AU - Caekebeke, Jo

AU - De Pooter, Tim

AU - Peeters, Karin

AU - Lübke, Ursula

AU - Van Den Broeck, Marleen

AU - Martin, Jean Jacques

AU - Cruts, Marc

AU - De Deyn, Peter P.

AU - Van Broeckhoven, Christine

AU - Dermaut, Bart

PY - 2006/4

Y1 - 2006/4

N2 - Among patients with frontotemporal lobar degeneration (FTLD), the respective frequencies of dominant I7q21-linked tau-negative FTLD (with unidentified molecular defect) and I7q21-linked tau-positive FTLD (due to MAPT mutations) remain unknown. Here, in a series of 98 genealogically unrelated Belgian FTLD patients, we identified an ancestral 8 cM MAPT containing haplotype in two patients belonging to multiplex families DR2 and DR8, without demonstrable MAPT mutations, in which FTLD was conclusively linked to 17q21 [maximum summed log of the odds (LOD) score of 5.28 at D17S931]. Interestingly, the same DR2-DR8 ancestral haplotype was observed in five additional familial FTLD patients, indicative of a founder effect. In the FTLD series, the DR2-DR8 ancestral haplotype explained 7% (7 out of 98) of FTLD and 17% (7 out of 42) of familial FTLD and was seven times more frequent than MAPT mutations (1 out of 98 or 1%). Clinically, DR2-DR8 haplotype carriers presented with FTLD often characterized by language impairment, and in one carrier the neuropathological diagnosis was FTLD with rare tau-negative ubiquitin-positive inclusions. Together, these results strongly suggest that the DR2-DR8 founder haplotype at 17q21 harbours a tau-negative FTLD causing mutation that is a much more frequent cause of FTLD in Belgium than MAPT mutations.

AB - Among patients with frontotemporal lobar degeneration (FTLD), the respective frequencies of dominant I7q21-linked tau-negative FTLD (with unidentified molecular defect) and I7q21-linked tau-positive FTLD (due to MAPT mutations) remain unknown. Here, in a series of 98 genealogically unrelated Belgian FTLD patients, we identified an ancestral 8 cM MAPT containing haplotype in two patients belonging to multiplex families DR2 and DR8, without demonstrable MAPT mutations, in which FTLD was conclusively linked to 17q21 [maximum summed log of the odds (LOD) score of 5.28 at D17S931]. Interestingly, the same DR2-DR8 ancestral haplotype was observed in five additional familial FTLD patients, indicative of a founder effect. In the FTLD series, the DR2-DR8 ancestral haplotype explained 7% (7 out of 98) of FTLD and 17% (7 out of 42) of familial FTLD and was seven times more frequent than MAPT mutations (1 out of 98 or 1%). Clinically, DR2-DR8 haplotype carriers presented with FTLD often characterized by language impairment, and in one carrier the neuropathological diagnosis was FTLD with rare tau-negative ubiquitin-positive inclusions. Together, these results strongly suggest that the DR2-DR8 founder haplotype at 17q21 harbours a tau-negative FTLD causing mutation that is a much more frequent cause of FTLD in Belgium than MAPT mutations.

KW - 17q21

KW - Founder mutation

KW - Frontotemporal lobar degeneration

KW - Tau-negative

KW - Ubiquitin-positive

UR - http://www.scopus.com/inward/record.url?scp=33645089933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645089933&partnerID=8YFLogxK

U2 - 10.1093/brain/awl029

DO - 10.1093/brain/awl029

M3 - Article

C2 - 16495329

AN - SCOPUS:33645089933

VL - 129

SP - 841

EP - 852

JO - Brain

JF - Brain

SN - 0006-8950

IS - 4

ER -